Pharmacological Treatment of a Rare Genetic Disease: N-acetylcysteine in Myopathy Associated Selenoprotein N-related Myopathy (SEPN1-RM)
Clinical trial NCT02505087 · TERMINATED
Trial details
- NCT number
- NCT02505087
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2018-04-24
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.